New PRPS1 variant p.(Met68Leu) located in the dimerization area identified in a French CMTX5 patient

Mol Genet Genomic Med. 2019 Sep;7(9):e875. doi: 10.1002/mgg3.875. Epub 2019 Jul 23.

Abstract

Background: CMTX5 is characterized by peripheral neuropathy, early-onset sensorineural hearing impairment, and optic neuropathy. Only seven variants have been reported and no genotype-phenotype correlations have yet been established. PRPS1 has a crystallographic structure, as it is composed of three dimers that constitute a hexamer.

Methods: Next-generation sequencing (NGS) was performed using a custom 92-gene panel designed for the diagnosis of Charcot-Marie-Tooth (CMT) and associated neuropathies.

Results: We report the case of a 35-year-old male, who had presented CMT and hearing loss since childhood associated to bilateral optic neuropathy without any sign of retinitis pigmentosa. A new hemizygous variant on chromosomic position X:106,882,604, in the PRPS1 gene, c.202A > T, p.(Met68Leu) was found. This change is predicted to lead to an altered affinity between the different subunits in the dimer, thereby may prevent the hexamer formation.

Conclusion: CMTX5 is probably under-diagnosed, as an overlap among the different features due to PRPS1 exists. Patients who developed polyneuropathy associated to sensorineural deafness and optic atrophy during childhood should be assessed for PRPS1.

Keywords: Charcot-marie-tooth; NGS; PRPS1; deafness; neuropathy.

MeSH terms

  • Adult
  • Charcot-Marie-Tooth Disease / diagnosis
  • Charcot-Marie-Tooth Disease / genetics*
  • Deafness / genetics
  • Dimerization*
  • Genetic Association Studies
  • Genetic Diseases, X-Linked / diagnosis
  • Genetic Diseases, X-Linked / genetics
  • Genotype
  • Hearing Loss, Central / genetics*
  • Hearing Loss, Sensorineural / diagnosis
  • Hearing Loss, Sensorineural / genetics*
  • Humans
  • Male
  • Models, Molecular
  • Muscular Disorders, Atrophic / genetics*
  • Optic Atrophies, Hereditary / genetics*
  • Pedigree
  • Phenotype
  • Polyneuropathies / diagnosis
  • Polyneuropathies / genetics*
  • Protein Conformation
  • Retinitis Pigmentosa
  • Ribose-Phosphate Pyrophosphokinase / chemistry
  • Ribose-Phosphate Pyrophosphokinase / genetics*

Substances

  • PRPS1 protein, human
  • Ribose-Phosphate Pyrophosphokinase

Supplementary concepts

  • Optic atrophy polyneuropathy deafness